• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

Exploring the Unique Properties and Applications of (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid (CAS No. 2231665-52-2)

In the realm of synthetic chemistry and pharmaceutical research, (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid (CAS No. 2231665-52-2) has emerged as a compound of significant interest. This structurally unique molecule, characterized by its bicyclo[1.1.1]pentane core, offers a fascinating case study in the design of novel bioactive compounds. Researchers and industry professionals are increasingly drawn to its potential applications in drug discovery, particularly in the development of peptidomimetics and enzyme inhibitors.

The bicyclo[1.1.1]pentane scaffold, a key feature of this compound, is renowned for its ability to mimic phenyl rings or tert-butyl groups while providing enhanced metabolic stability and reduced steric hindrance. This makes (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid a valuable building block in medicinal chemistry. Recent studies highlight its utility in creating conformationally constrained peptides, which are pivotal in targeting protein-protein interactions—a hot topic in oncology and neurodegenerative disease research.

One of the most searched questions in the field is: "How does bicyclo[1.1.1]pentane improve drug bioavailability?" The answer lies in the scaffold's ability to reduce lipophilicity while maintaining spatial geometry, a property that (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid exemplifies. This aligns with the growing demand for bioisosteres that can replace traditional aromatic rings without compromising efficacy—a trend driven by the need for safer and more effective therapeutics.

From a synthetic perspective, the preparation of (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid involves innovative strategies to functionalize the strained bicyclo[1.1.1]pentane system. Recent advancements in C-H activation and photocatalysis have opened new routes to access such frameworks, addressing another frequently asked question: "What are the latest methods to synthesize bicyclo[1.1.1]pentane derivatives?" These techniques not only improve yields but also align with green chemistry principles, a priority for modern pharmaceutical manufacturing.

Beyond drug development, this compound has sparked interest in materials science. Its rigid structure and functional groups make it a candidate for designing high-performance polymers or supramolecular assemblies. As researchers explore AI-driven molecular design, compounds like (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid serve as test cases for machine learning models predicting novel bioisosteres—a cutting-edge intersection of chemistry and artificial intelligence.

In summary, (2S)-2-Amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid (CAS No. 2231665-52-2) represents a convergence of structural innovation and practical utility. Its role in addressing challenges like drug permeability, metabolic stability, and 3D molecular diversity ensures its relevance in both academic and industrial settings. As the scientific community continues to unravel its potential, this compound stands as a testament to the power of creative molecular architecture in solving real-world problems.

• 2682112-40-7(2-Amino-2-(3-(tert-butyl)bicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride)
• 1807854-19-8(2-Amino-2-{bicyclo[1.1.1]pentan-1-yl}acetic acid hydrochloride)
• 1932128-02-3((2R)-2-amino-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)acetic acid)
• 2227197-63-7((2R)-2-amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid;hydrochloride)
• 2103536-04-3(2-Amino-2-(3,3-dimethylcyclobutyl)acetic acid)
• 2231665-53-3((2S)-2-amino-2-(1-bicyclo[1.1.1]pentanyl)acetic acid;hydrochloride)
• 1822588-90-8(2-amino-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)acetic acid)
• 944278-22-2((S)-2-Amino-2-(3-(tert-butyl)bicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride)
• 944313-19-3((2S)-2-amino-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)acetic acid)
• 1807854-21-2(2-amino-2-{bicyclo[1.1.1]pentan-1-yl}acetic acid)